Citations Report

Citation Index - Clinical Investigation [920 Articles]

The articles published in Clinical Investigation have been cited 920 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Clinical Investigation.

  • Fang W. Modeling Arbitrarily Interval-Censored Survival Data with External Time-Dependent Covariates. UNIVERSITY OF NORTHERN COLORADO; 2015.

    View at Publisher | View at Google Scholar
  • Song G, Ivanova A. Enrollment and Stopping Rules for Managing Toxicity Requiring Long Follow-Up in Phase II Oncology Trials. Journal of biopharmaceutical statistics. 2015 Nov 2;25(6):1206-14.

    View at Publisher | View at Google Scholar
  • Antonijevic Z. Adaptive Clinical Trials. Clinical Investigation. 2015 Apr;5(4):353-4.

    View at Publisher | View at Google Scholar
  • Ivanova A, Paul B, Marchenko O, Song G, Patel N, Moschos SJ. Nine-year change in statistical design, profile, and success rates of Phase II oncology trials. Journal of Biopharmaceutical Statistics. 2016 Jan 2;26(1):141-9.

    View at Publisher | View at Google Scholar
  • Antonijevic Z. Adaptive Clinical Trials. Clinical Investigation. 2015 Apr;5(4):353-4.

    View at Publisher | View at Google Scholar
  • Antonijevic Z. Adaptive Clinical Trials. Clinical Investigation. 2015 Apr;5(4):353-4.

    View at Publisher | View at Google Scholar
  • Lin J, Bunn V. Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials. Contemporary Clinical Trials. 2017 Jan 13.

    View at Publisher | View at Google Scholar
  • Urach S, Posch M. Multi‐arm group sequential designs with a simultaneous stopping rule. Statistics in Medicine. 2016 Dec 30;35(30):5536-50.

    View at Publisher | View at Google Scholar
  • Lu X, He Y, Wu SS. Interval estimation in multi-stage drop-the-losers designs. Statistical methods in medical research. 2016 Mar 14:0962280215626748.

    View at Publisher | View at Google Scholar
  • Dimairo M, Todd S, Julious S, Jaki T, Wason J, Hind D, Mander A, Weir C, Koenig F, Altman D, Nicholl J. ACE Project Protocol. Development of a CONSORT Extension for adaptive clinical trials. University of Sheffield

    View at Publisher | View at Google Scholar
  • Antonijevic Z. Adaptive Clinical Trials. Clinical Investigation. 2015 Apr;5(4):353-4.

    View at Publisher | View at Google Scholar
  • Antonijevic Z. Adaptive Clinical Trials. Clinical Investigation. 2015 Apr;5(4):353-4.

    View at Publisher | View at Google Scholar
  • Moran JL, Solomon PJ. New initiatives in critical care: distinguishing hype from hope. Critical Care and Resuscitation. 2016 Sep;18(3):141.

    View at Publisher | View at Google Scholar
  • Hu Y. Generalized Efron's biased coin design and its theoretical properties. Journal of Applied Probability. 2016 Jun 1;53(02):327-40.

    View at Publisher | View at Google Scholar
  • Gelhorn HL, Kulke MH, O’Dorisio T, Yang QM, Jackson J, Jackson S, Boehm KA, Law L, Kostelec J, Auguste P, Lapuerta P. Patient-reported symptom experiences in patients with carcinoid syndrome after participation in a study of telotristat etiprate: a qualitative interview approach. Clinical therapeutics. 2016 Apr 30;38(4):759-68.

    View at Publisher | View at Google Scholar
  • Goldberg DR, De Lombaert S, Aiello R, Bourassa P, Barucci N, Zhang Q, Paralkar V, Valentine J, Zavadoski W. Discovery of spirocyclic proline tryptophan hydroxylase-1 inhibitors. Bioorganic & medicinal chemistry letters. 2016 Feb 15;26(4):1124-9.

    View at Publisher | View at Google Scholar
  • Kulke MH, Hörsch D, Caplin ME, Anthony LB, Bergsland E, Öberg K, Welin S, Warner RR, Lombard-Bohas C, Kunz PL, Grande E. Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome. Journal of Clinical Oncology. 2016 Oct 31;35(1):14-23.

    View at Publisher | View at Google Scholar
  • Lamarca A, Barriuso J, McNamara MG, Hubner RA, Valle JW. Telotristat ethyl: a new option for the management of carcinoid syndrome. Expert Opinion on Pharmacotherapy. 2016 Dec 11;17(18):2487-98.

    View at Publisher | View at Google Scholar
  • Patel D, Chan D, Cehic G, Pavlakis N, Price TJ. Systemic therapies for advanced gastroenteropancreatic neuroendocrine tumors. Expert Review of Endocrinology & Metabolism. 2016 Jul 3;11(4):311-27.

    View at Publisher | View at Google Scholar
  • Cervera R. La investigación sobre tratamientos biológicos en el lupus eritematoso sistémico. Medicina Clínica. 2017;148(2):67-8.

    View at Publisher | View at Google Scholar

Relevant Topics